Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025. SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a ...

Outset Medical, Inc. has secured up to $125 million in new debt financing, set to mature in 2030, and plans to retire $200 million of prior debt.

Outset Medical (OM 36.40%), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and ...

Medical device companies can't market or ship their products unless the U.S. Food and Drug Administration (FDA) says they can. So when Outset Medical (OM-3.52%) suspended shipments of its Tablo ...

Outset Medical shares have rallied more than 30% this month on news of the FDA approval. With the headwinds now behind it, the business has multiple positive catalysts going forward.

Outset Medical (OM) has received a new Buy rating, initiated by BTIG analyst, Marie Thibault. Marie Thibault’s rating is based on a variet ...

SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...

Outset Medical's revenue CAGR is up 95 percent since 2019 and should continue to generate revenue growth based upon growing home care and reimbursements. On the acute care side, ...

Outset Medical, Inc. OM shares soared 15% in the last trading session to close at $19.97. The move was backed by solid volume with far more shares changing hands than in a normal session.